Gregory Harochaw Pharmacy Manager Tache Pharmacy (204) 233-3469.

Slides:



Advertisements
Similar presentations
Mood Management underlying cause Viagra M.U.S.E. Vacuum Device Injection Alprostadil Implants Alternative Medicine Counseling By Ashok Koparday Consultant.
Advertisements

Erectile Dysfunction - A rising problem
If You Have An Erection Lasting Longer Than 4 Hours, What Should You REALLY Do??? Evidence in the ED Alex Katz, PGY3 12/04/13.
Erectile Dysfunction Steven Lun The Townsville Hospital JCU
Sexual Health & Well-Being TM A New Approach to Men’s Sexual Health Medical Marketing Division of FastSize LLC.
Campbell’s Review – Chapter – 801 PROSTHETIC SURGERY FOR ERECTILE DYSFUNCTION.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence July–August 2013.
No. 100 Comparison between AMS700TM CX and ColoplastTM Titan inflatable penile prostheses for Peyronie’s disease treatment and remodelling: Clinical outcomes.
Evolving Strategy in Erectile Dysfunction Management TY Chu Urology Division Department of Surgery PYNEH.
ERECTILE DYSFUNCTION.
Journal Club Alcohol and Health: Current Evidence January–February 2007.
1 Male Sexual Dysfunction. 2 Hypoactive Sexual Desire Disorder Affects 15% of men Typically associated with a medical condition, mental health issues,
Presentation on ESPRIT & STALWART Cycling Washington ICC Group Meeting, June 2007 CCG Training Session Prepared by: Dale C. Sattergren ESPRIT & STALWART.
Sex & Intimacy After Prostate Cancer Jeffrey Albaugh, PhD, APRN, CUCNS Jesse Brown VA Medical Center NorthShore University HealthCare Urology Sexual Health.
Prostate Cancer Symposium An Educational Initiative For Patients, Spouses, Advocates and Healthcare Professionals Restoring Quality of Life: Managing Side-effects/Pain.
Prostate Cryotherapy Minimally Invasive Cancer Treatment PM-3590 Rev A 08/11 This information is intended for general patient education purposes only in.
Erectile dysfunction The ins and outs Louise MacPherson.
A Prospective Study of the Impact of Bladder Incontinence Surgery on Sexual Satisfaction K. Witzke, DO, Gregory McIntosh, DO, FACOS, Jeffrey Schock, DO,
Intro  Erectile dysfunction (ED), also known as impotence, is the inability to get and maintain an erection that is sufficient for satisfactory sexual.
European Society of Cardiology Cardiovascular diseases in women.
Erectile Dysfunction Stephen Mark Christchurch. Normal erectile function: Physical and Psychological factors.
1 THE 3 I’s of UROLOGY Presented by Dr. Mark P. Posner Louisiana Occupational Health Conference August 4, 2012 Baton Rouge, La. 1.
Managing the side effects of a radical prostatectomy
Can pharmacists improve outcomes in hypertensive patients? Sookaneknun P (1), Richards RME (2), Sanguansermsri J(1), Teerasut C (3) : (1)Faculty of Pharmacy,
Nancy Houston-Miller RN
ERECTILE DYSFUNCTION ___________________________ FOR THE GENERALIST.
Statistics: Unlocking the Power of Data Lock 5 STAT 250 Dr. Kari Lock Morgan Collecting Data: Randomized Experiments SECTION 1.3 Control/comparison group.
Copyright © 2007 Pearson Education Canada13-1 Sexual Dysfunctions Chapter 13 This multimedia product and its contents are protected under copyright law.
Lenalidomide Maintenance After Stem-Cell Transplantation for Multiple Myeloma: Follow-Up Analysis of the IFM Trial Attal M et al. Proc ASH 2013;Abstract.
Date of download: 5/27/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Efficacy and Safety of Tadalafil in Men With Erectile.
First Best ever medication for Impotence.  In simple language, ED is a failure of satisfactory sexual performance.  Another term which is used instead.
SISPE PROJECT: Use of small intestinal submucosa graft for the surgical management of Peyronie's disease Glina S 1, Toscano IL 1, Baptistussi M 2, Teloken.
Side effects following radical treatments for prostate cancer Mary Symons Helen Worth Worcestershire Acute Hospitals NHS Trust.
Erectile Dysfunction (ED) What Men Should Know Paul Gittens, MD, FACS Medical Director Philadelphia Center of Sexual Medicine.
 Erectile Dysfunction (ED) is a sexual disorder characterized by the inability to attain and sustain an erection during lovemaking.  Worldwide, millions.
Life after Prostate Cancer and its treatment Mr Sanjeev Pathak Consultant Urological Surgeon and Cancer Lead Doncaster and Bassetlaw NHS Trust 12 th March.
Link Between Chronic Lower Back Pain And Erectile Dysfunction
Ege Can Serefoglu, MD, FECSM UroKlinik, Istanbul, Turkey
Vascular Evaluation in Erectile Dysfunction
Disfunzione erettile dopo prostatectomia radicale
Attal M et al. Proc ASH 2010;Abstract 310.
Male Sexual Anatomy and Physiology
How I talk to my patients about HIFU
Jabbour E et al. Proc ASH 2015;Abstract 83.
The Effects of Sexual Therapy Interventions for Sexual problems.
Erectile Dysfunction Treatment and causes (Tadaga)
First & second line treatments for ED
Section IV: Novel therapies for the treatment of erectile dysfunction
Is It Safe to use Kamagra ?Kamagra.  Erectile dysfunction(ED) is a type of sexual disorder in men.  Erectile dysfunction is defined as the inability.
Apcalis Oral Jelly: Usage, Dosage, Composition. Summary on Apcalis Oral Jelly Tadalafil is the active constituent present in the branded medicine Apcalis.
Kamagra HOW TO USE KAMAGRA FOR ERECTION PROBLEM?.
Generic Viagra: Finest ED Medicine
Vardenafil- one of the best remedy for ED
Male Sexual Anatomy and Physiology
Erectile dysfunction and Penile rehabilitation following radical prostatectomy 김 세 웅 여의도성모병원비뇨기과.
Volume 70, Issue 3, Pages (September 2016)
Impotence of Male Disease
Diabetes & Male Reproductive Health
What is Erectile Dysfunction (ED)? Erectile dysfunction (ED) is a form of sexual disorder in men in which a man is not able to obtain or maintain the.
Bent Male Organ Treatment: Understanding and Coping with Peyronie’s Disease and How to Deal with it
Volume 55, Issue 2, Pages (February 2009)
Section overview: Cardiometabolic risk reduction
Introduction to Psychosexual Medicine
Penile Injection Therapy
By
Speaker : Chin–Hsiang Tu
DENERHTN Trial design: Patients with resistant hypertension were randomized to renal denervation plus standardized stepped-care antihypertensive treatment.
Bent Male Organ Problems: A New Treatment for Peyronie’s Disease Shows Promise.
Male Organ Rejuvenation Treatments: Do They Really Work?
IN THE TREATMENT OF ERECTILE DYSFUNCTION
Presentation transcript:

Gregory Harochaw Pharmacy Manager Tache Pharmacy (204)

Nerve Function  After careful prostatectomy where the erectile nerves are preserved they can be dormant for 12 – 24 months  With radiation therapy the nerves are in the field of radiation  They allow the smooth muscle to relax & allow the lacunar spaces to expand & fill with blood

Understanding Penile Rehabilitation  Until recently the time interval to return erectile function after radical prostatectomy can be up to 2 years  This 2 year period might be due to “neuropraxia” or transient cavernosal nerve dysfunction  Historically, patients have been encouraged during this period to continue waiting for the return or erectile function without the need for active intervention Rev Urol. Fall; 8(4): ; J.E. Dall’’Erea et al.:Penile Rehabilitation After Radical Prostatectomy:Important Therapy of Wishful Thinking?

Understanding Penile Rehabilitation  PO 2 Flaccid: 30 – 40mm Hg  PO 2 Erect state: 90 – 100mm Hg  PO 2 Arteriogenic: 65mm Hg  PO 2 Venous leakage: 71mm Hg  This low PO 2 can lead to  collagen synthesis Rev Urol. Fall; 8(4): ; J.E. Dall’’Erea et al.:Penile Rehabilitation After Radical Prostatectomy:Important Therapy of Wishful Thinking?

Understanding Penile Rehabilitation  Prolonged flaccid state after nerve-sparing radical prostatectomy  collagen deposition in the corpus cavernosum  lead to tissue hypoxia which can result in damage to the smooth muscle  lead to irreversible veno- occlusive disease (venous leakage) Rev Urol. Fall; 8(4): ; J.E. Dall’’Erea et al.:Penile Rehabilitation After Radical Prostatectomy:Important Therapy of Wishful Thinking?

Understanding Penile Rehabilitation  This is all theoretical as it is difficult to prove how this actually starts and remains a topic of debate  Formation of fibrotic tissue does form in the corpus cavernosum after a radical prostatectomy Rev Urol. Fall; 8(4): ; J.E. Dall’’Erea et al.:Penile Rehabilitation After Radical Prostatectomy:Important Therapy of Wishful Thinking?

Understanding Penile Rehabilitation  Several studies have been performed evaluating the effectiveness of artificially induced erection after surgery:  PGE 1 injections  Vacuum devices  PDE-5i (Viagra, Cialis & Levitra)

Understanding Penile Rehabilitation  Montorsi & colleagues evaluated using alprostadil injections at 1 month after bilateral nerve sparing radical prostatectomy  Investigators found that a higher rate of recovery of spontaneous erections after 6 months compared to no treatment  67% of men in the study group had return of spontaneous erections sufficient for intercourse at 6 months compared to 20% of men who did not inject  53% of patients who did not receive injections demonstrated venous leakage vs. 17% of patients receiving injection therapy

Understanding Penile Rehabilitation  2 flaws in study  No placebo group used  Definition of “complete recovery” made interpretation of results challenging  Also using alprostadil itself may lead to prevention of fibrosis in corpus cavernosum

Understanding Penile Rehabilitation  Mulhall & coworkers followed 132 patients through an 18 month period after they were placed in “rehabilitation” or “no rehabilitation” groups after radical prostatectomy  Rehabilitation group took either sildenafil or intracavernosal alprostadil to induce erection 3 times weekly starting within the 1 st 4 weeks after surgery

Understanding Penile Rehabilitation  After 18 months of follow-up  52% of men in the rehabilitation group (RG) reported spontaneous erections  19% of men in the non-rehabilitation group (NRG) reported spontaneous erections  Also 64% of men in RG vs. 24% of men in NRG responded to sildenafil after the 18 months and were able to have an erection sufficient for intercourse

Understanding Penile Rehabilitation  Limitation in this study is that it was a non- randomized study (patients chose if they wanted treatment or not)  However, the results are in agreement with the Montorsi study suggesting a regimented rehabilitation protocol might improve overall return of erection function after radical prostatectomy

Understanding Penile Rehabilitation  Gontero & colleagues investigated alprostadil injections at various points after non-nerve- sparing radical prostatectomy  70% of patients receiving injections within 3 months of surgery were able to achieve erections for intercourse vs 40% for people receiving injections after 3 months of surgery  Summary was that people should receive penile rehabilitation within 3 months of surgery

Understanding Penile Rehabilitation  Raina & coworkers evaluated daily use of vacuum constriction device (VCD) within 2 months of patients receiving nerve-sparing or non-nerve sparing radical prostatectomy  After 9 months of treatment 17% of patients using the device had a return of natural erections sufficient for intercourse vs. 11% of patients in non-treatment group

Understanding Penile Rehabilitation  23% of patients in treatment group reported a  in penile length & circumference vs. 60% in non-treatment group  These findings suggest that fibrotic changes leading to penile shortening and possible venous leakage might be minimized

Understanding Penile Rehabilitation  Padma-Nathan & colleagues gave either nightly sildenafil treament or placebo for 36 weeks starting 4 weeks after a nerve-sparing radical prostatectomy  After 48 weeks 27% of the treatment group reported erections vs. 4% in placebo group  4% is extremely low & study only involved 76 patients. A larger trial may be required to extrapolate results

Understanding Penile Rehabilitation  Raina & coworkers did a study with the use of PDE-5i after an initial protocol of penile rehabilitation using intracavernosal injections or VCD after radical prostatectomy  Used sildenafil in dissatisfied patients using a VCD for about 4 months & found after 8 months of combined treatment 77% improvement in rigidity/patient satisfaction & 30% of patients with a return to natural erections

Understanding Penile Rehabilitation  Montorsi & colleagues used a combination of sildenafil & intracavernous alprostadil injections in patients undergoing nerve- sparing radical prostatectomy  Patients started on injections within 1 month and sildenafil after 4 months vs. sidenafil alone after 4 months  82% of men in combined group responded to sildenafil vs. 52% sildenafil-only group

Conclusion  Significant fibrotic changes in the corpous cavernosum develop after a prolonged period of penile flaccidity after a radical prostatectomy  Exact etiology is unknown although strong evidence suggest hypoxia may induce fibrotic changes  Many physicians are using some type of erectogenic treatment after a surgery in an effort to enhance the return of sexual function

Conclusion  Limited data shows the possible role of chronic use of PDE-5i post-prostatectomy in enhancing the return of sexual function  Patients need to be aware that the preliminary data on the exact benefit imparted on penile rehabilitation & which treatment regimen that is most effective will remain highly controversial until better data becomes available

Treatment  Start treatment within 4 months after prostatectomy  Use of a PDE5i daily or the use of an ED injection 3 times weekly for 6 months  Use a vacuum pump to help regain length  Bring penis to a full erection & hold for 1 minute  Repeat up to 4 times over 10 minutes  Use on off days if using ED injection  Use 5 times/week for 6 months – 1 year if on PDE5i